New endocrine approaches in the treatment of breast cancer
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 52 (3) , 122-132
- https://doi.org/10.1016/s0753-3322(98)80090-5
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.Journal of Clinical Investigation, 1994
- Droloxifene, a new antiestrogen: Its role in metastatic breast cancerBreast Cancer Research and Treatment, 1994
- Transcription Activation by Nuclear ReceptorsJournal of Receptor Research, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Pharmacologic and Biologic Properties of Droloxifene, A New AntiestrogenAmerican Journal of Clinical Oncology, 1991